Agatha Jassem
From Wikipedia the free encyclopedia
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
Agatha Jassem | |
---|---|
Nationality | Canadian |
Alma mater | University of British Columbia |
Occupation | clinical microbiologist |
Agatha Jassem is a Canadian clinical microbiologist and the program head of the Virology Lab at the British Columbia Centre for Disease Control Public Health Laboratory,[1] and a clinical assistant professor in the Department of Pathology & Laboratory Medicine at the University of British Columbia in Vancouver, British Columbia, Canada.[2]
Jassem obtained her PhD at the University of British Columbia, followed by a fellowship in Clinical Microbiology at the National Institutes of Health.[3] Her research focuses the detection of healthcare-and community-associated infections, emerging pathogens, and drug resistance determinants.
During the COVID-19 pandemic response, Jassem led research efforts on COVID-19 breakthrough infections from vaccinated individuals,[4][5] SARS-CoV-2 population level seroprevalence,[6] antibody response [7] as well as collaborating on research on securing reagents for COVID-19 during world-wide shortages,[8] and the role of ACEII. [9]
References[edit]
- ^ "Agatha Jassem". bccdc.ca. Retrieved 2021-09-20.
- ^ "Agatha Jassem". Pathology. Retrieved 2021-09-20.[permanent dead link]
- ^ "Agatha Jassem". Pathology. Retrieved 2021-09-20.[permanent dead link]
- ^ "COVID-19 Smiles – The Study of Vaccine Escape Mutants | COVID-19 Research". covid19.research.ubc.ca. Retrieved 2021-09-20.
- ^ "COVID-19 research initiatives at UBC among those funded by first-time partnership". UBC Faculty of Medicine. 2021-05-21. Retrieved 2021-09-28.
- ^ "Population-Based Study Of Coronavirus Antibody Cross-Reactivity To Inform SARS-CoV-2 Seroprevalence | COVID-19 Research". covid19.research.ubc.ca. Retrieved 2021-09-20.
- ^ "Characterizing Antibody Response to Emerging COVID-19 Virus (CARE COVID-19) | COVID-19 Research". covid19.research.ubc.ca. Retrieved 2021-09-20.
- ^ "Securing Reagent Supplies and Scaling COVID-19 | COVID-19 Research". covid19.research.ubc.ca. Retrieved 2021-09-20.
- ^ "Prognostication of ACE II Receptor (PACEiiR) | COVID-19 Research". covid19.research.ubc.ca. Retrieved 2021-09-20.